• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYC的作用机制:引导谷氨酰胺代谢走向独特的癌细胞表型。

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.

作者信息

Tambay Vincent, Raymond Valérie-Ann, Bilodeau Marc

机构信息

Laboratoire d'Hépatologie Cellulaire, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada.

Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada.

出版信息

Cancers (Basel). 2021 Sep 6;13(17):4484. doi: 10.3390/cancers13174484.

DOI:10.3390/cancers13174484
PMID:34503295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8431116/
Abstract

Metabolic reprogramming and deregulated cellular energetics are hallmarks of cancer. The aberrant metabolism of cancer cells is thought to be the product of differential oncogene activation and tumor suppressor gene inactivation. MYC is one of the most important oncogenic drivers, its activation being reported in a variety of cancer types and sub-types, among which are the most prevalent and aggressive of all malignancies. This review aims to offer a comprehensive overview and highlight the importance of the c-Myc transcription factor on the regulation of metabolic pathways, in particular that of glutamine and glutaminolysis. Glutamine can be extensively metabolized into a variety of substrates and be integrated in a complex metabolic network inside the cell, from energy metabolism to nucleotide and non-essential amino acid synthesis. Together, understanding metabolic reprogramming and its underlying genetic makeup, such as MYC activation, allows for a better understanding of the cancer cell phenotype and thus of the potential vulnerabilities of cancers from a metabolic standpoint.

摘要

代谢重编程和细胞能量代谢失调是癌症的标志。癌细胞的异常代谢被认为是原癌基因激活和肿瘤抑制基因失活差异的产物。MYC是最重要的致癌驱动因素之一,据报道它在多种癌症类型和亚型中被激活,其中包括所有恶性肿瘤中最常见和侵袭性最强的类型。本综述旨在提供全面概述,并强调c-Myc转录因子对代谢途径调控的重要性,特别是对谷氨酰胺和谷氨酰胺分解代谢途径的调控。谷氨酰胺可以广泛代谢为多种底物,并整合到细胞内复杂的代谢网络中,从能量代谢到核苷酸和非必需氨基酸的合成。总之,了解代谢重编程及其潜在的基因组成,如MYC激活,有助于从代谢角度更好地理解癌细胞表型,进而了解癌症的潜在脆弱性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/8b5fdd274f99/cancers-13-04484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/98541b782431/cancers-13-04484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/8f44e9f367b8/cancers-13-04484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/8b5fdd274f99/cancers-13-04484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/98541b782431/cancers-13-04484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/8f44e9f367b8/cancers-13-04484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222d/8431116/8b5fdd274f99/cancers-13-04484-g003.jpg

相似文献

1
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.MYC的作用机制:引导谷氨酰胺代谢走向独特的癌细胞表型。
Cancers (Basel). 2021 Sep 6;13(17):4484. doi: 10.3390/cancers13174484.
2
Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.肿瘤抑制因子NDRG2通过抑制c-Myc表达来抑制结肠癌细胞中的糖酵解和谷氨酰胺分解代谢。
Oncotarget. 2015 Sep 22;6(28):26161-76. doi: 10.18632/oncotarget.4544.
3
Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.分化抑制因子1转录因子促进肝癌细胞的代谢重编程。
FASEB J. 2016 Jan;30(1):262-75. doi: 10.1096/fj.15-277749. Epub 2015 Sep 1.
4
Impact of MYC in regulation of tumor cell metabolism.MYC在肿瘤细胞代谢调控中的作用
Biochim Biophys Acta. 2015 May;1849(5):563-9. doi: 10.1016/j.bbagrm.2014.07.004. Epub 2014 Jul 17.
5
MYC and metabolism on the path to cancer.MYC与癌症发展过程中的新陈代谢
Semin Cell Dev Biol. 2015 Jul;43:11-21. doi: 10.1016/j.semcdb.2015.08.003. Epub 2015 Aug 12.
6
Reprogramming of Cancer Metabolism by MYC.MYC对癌症代谢的重编程
Front Cell Dev Biol. 2017 Apr 11;5:35. doi: 10.3389/fcell.2017.00035. eCollection 2017.
7
Oncogene-Driven Metabolic Alterations in Cancer.癌症中癌基因驱动的代谢改变
Biomol Ther (Seoul). 2018 Jan 1;26(1):45-56. doi: 10.4062/biomolther.2017.211.
8
MYC and tumor metabolism: chicken and egg.MYC与肿瘤代谢:因果难定。
EMBO J. 2017 Dec 1;36(23):3409-3420. doi: 10.15252/embj.201796438. Epub 2017 Nov 10.
9
Glutaminolysis: A Hallmark of Cancer Metabolism.谷氨酰胺分解:癌症代谢的一个标志
Annu Rev Biomed Eng. 2017 Jun 21;19:163-194. doi: 10.1146/annurev-bioeng-071516-044546. Epub 2017 Mar 8.
10
Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.线粒体p32在表达Myc的脑癌中上调,并介导谷氨酰胺成瘾。
Oncotarget. 2015 Jan 20;6(2):1157-70. doi: 10.18632/oncotarget.2708.

引用本文的文献

1
The long antisense non-coding RNA HOXA transcript at the distal tip (LncRNA HOTTIP) in health and disease: a comprehensive review and in silico analysis.健康与疾病中的远端长反义非编码RNA HOXA转录本(LncRNA HOTTIP):综述与计算机分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 5. doi: 10.1007/s00210-025-04372-9.
2
Infectious Spleen and Kidney Necrosis Virus ORF093R and ORF102R Regulate Glutamate Metabolic Reprogramming to Support Virus Proliferation by Interacting with c-Myc.传染性脾肾坏死病毒的ORF093R和ORF102R通过与c-Myc相互作用调节谷氨酸代谢重编程以支持病毒增殖。
Int J Mol Sci. 2025 Jan 16;26(2):718. doi: 10.3390/ijms26020718.
3

本文引用的文献

1
The Metabolic Landscape of RAS-Driven Cancers from biology to therapy.从生物学原理到治疗方法:RAS驱动型癌症的代谢格局
Nat Cancer. 2021 Mar;2(3):271-283. doi: 10.1038/s43018-021-00184-x. Epub 2021 Mar 24.
2
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.MycN 和 c-Myc 之间的相互作用调节了神经母细胞瘤在谷氨酰胺剥夺时的放射抵抗和癌症干细胞表型。
Theranostics. 2020 May 16;10(14):6411-6429. doi: 10.7150/thno.42602. eCollection 2020.
3
Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells.
The interplay of EBV virus and cell metabolism in lung cancer.
EBV病毒与肺癌细胞代谢之间的相互作用。
J Cell Mol Med. 2024 Nov;28(22):e70088. doi: 10.1111/jcmm.70088.
4
Establishment and Characterization of Three Human Ocular Adnexal Sebaceous Carcinoma Cell Lines.建立并鉴定三种人眼附属器皮脂腺癌细胞系。
Int J Mol Sci. 2024 Sep 23;25(18):10183. doi: 10.3390/ijms251810183.
5
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.MYC 和 KRAS 合作:癌症治疗机遇中的历史挑战。
Signal Transduct Target Ther. 2024 Aug 21;9(1):205. doi: 10.1038/s41392-024-01907-z.
6
Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma.谷氨酰胺氨基酸转运蛋白表达重编程与肝细胞癌的预后意义。
Int J Mol Sci. 2024 Jul 10;25(14):7558. doi: 10.3390/ijms25147558.
7
Targeting the glutamine-arginine-proline metabolism axis in cancer.靶向癌症中的谷氨酰胺-精氨酸-脯氨酸代谢轴。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2367129. doi: 10.1080/14756366.2024.2367129. Epub 2024 Jul 25.
8
Unfolding the mysteries of heterogeneity from a high-resolution perspective: integration analysis of single-cell multi-omics and spatial omics revealed functionally heterogeneous cancer cells in ccRCC.从高分辨率视角揭示异质性的奥秘:单细胞多组学和空间组学的整合分析揭示了 ccRCC 中功能异质的癌细胞。
Aging (Albany NY). 2024 Jun 26;16(13):10943-10971. doi: 10.18632/aging.205974.
9
Metabolic Reprogramming in Thyroid Cancer.甲状腺癌中的代谢重编程。
Endocrinol Metab (Seoul). 2024 Jun;39(3):425-444. doi: 10.3803/EnM.2023.1802. Epub 2024 Jun 10.
10
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.低表达的 NDRG2 受 MYC/MIZ-1 复合物和甲基化调控,可预测 DLBCL 患者的不良预后。
Ann Hematol. 2024 Aug;103(8):2877-2892. doi: 10.1007/s00277-024-05829-2. Epub 2024 Jun 6.
丝氨酸生物合成途径支持维持伯基特淋巴瘤细胞代谢和表观遗传重编程所必需的MYC-miR-494-EZH2前馈回路。
Cancers (Basel). 2020 Mar 3;12(3):580. doi: 10.3390/cancers12030580.
4
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.破坏谷氨酰胺分解增强化疗效果,而 NRF2 促进 KRAS 驱动的胰腺癌细胞的化疗耐药性。
Cancer Res. 2020 Apr 15;80(8):1630-1643. doi: 10.1158/0008-5472.CAN-19-1363. Epub 2020 Jan 7.
5
circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling.环状 RNA HECTD1 通过靶向 miR-1256 并激活 β-catenin/c-Myc 信号通路促进胃癌进展中的谷氨酰胺分解代谢。
Cell Death Dis. 2019 Aug 2;10(8):576. doi: 10.1038/s41419-019-1814-8.
6
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression.转录激活因子 4 (ATF4)在肿瘤进展过程中把 MYC 依赖性翻译活性与能量需求联系起来。
Nat Cell Biol. 2019 Jul;21(7):889-899. doi: 10.1038/s41556-019-0347-9. Epub 2019 Jul 1.
7
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides.癌细胞调整信号通路以促进核苷酸的从头合成。
Cancers (Basel). 2019 May 17;11(5):688. doi: 10.3390/cancers11050688.
8
Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells.尼古丁暴露通过提高 O-GlcNAc 和 GFAT 的表达促进乳腺癌细胞的上皮间质转化和侵袭。
Cell Death Dis. 2019 Apr 24;10(5):343. doi: 10.1038/s41419-019-1577-2.
9
Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.丙酮酸羧化酶介导的氨补充作用通过维持肝脏三羧酸循环和氧化还原代谢来提高抗氧化能力。
Cell Metab. 2019 Jun 4;29(6):1291-1305.e8. doi: 10.1016/j.cmet.2019.03.014. Epub 2019 Apr 18.
10
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.SIRT2/cMYC 通路通过代谢重编程抑制胆管癌细胞的过氧化相关凋亡。
Neoplasia. 2019 May;21(5):429-441. doi: 10.1016/j.neo.2019.03.002. Epub 2019 Mar 29.